NCT07610330

Brief Summary

Patients who have undergone arthrodesis of the first metatarsophalangeal joint due to hallux valgus or hallux rigidus are invited to participate in this study, which aims to investigate how the foot functions after this operation. Patients between 18 and 60 years of age at the time of surgery are eligible to participate. Questionnaires will be distributed to assess current sports function compared with function prior to surgery. Particular focus will be placed on function during cross-country skiing.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
18mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jun 2026Dec 2027

First Submitted

Initial submission to the registry

May 20, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

May 27, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 20, 2026

Last Update Submit

May 20, 2026

Conditions

Keywords

Return to sportFirst metatarsophalangeal jointArthrodesis

Outcome Measures

Primary Outcomes (1)

  • Return to Cross country skiing

    At least 1 year after surgery

Interventions

ArthrodesisPROCEDURE

Arhtrodesis of the first metatarsophalangeal joint

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent arthrodesis of the first metatarsophalangeal joint at Oslo University Hospital, Martina Hansens Hospital, or Sørlandet Hospital within the past 1-5 years will be evaluated for enrollment

You may qualify if:

  • Patients who has underwent arthrodesis of the first metatarsofalangeal joint because of hallux rigidus or severe hallux valgus
  • Patients at age 18-60 at the date of surgery
  • At least one year follow-up, and maximum 5 years since surgery.

You may not qualify if:

  • Non-Norwegian-speaking patients.
  • Impaired walking function.
  • Inability to cooperate.
  • Concomitant osteotomy of other metatarsals.
  • Revision arthrodeses.
  • Patients undergoing follow-up or evaluation for pseudoarthrosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hallux RigidusHallux ValgusAnkylosis

Interventions

Arthrodesis

Condition Hierarchy (Ancestors)

Foot Deformities, AcquiredFoot DeformitiesMusculoskeletal DiseasesJoint Diseases

Intervention Hierarchy (Ancestors)

Orthopedic ProceduresSurgical Procedures, Operative

Study Officials

  • Elisabeth Ellingsen Husebye, MD, PhD, Prof.

    Oslo University Hospital

    STUDY DIRECTOR

Central Study Contacts

Andreas Døble, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopedic Resident

Study Record Dates

First Submitted

May 20, 2026

First Posted

May 27, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

May 27, 2026

Record last verified: 2026-05